<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report two pediatric patients with unclassified <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) by the French-American-British (FAB) group </plain></SENT>
<SENT sid="1" pm="."><plain>Both cases had clinical and hematological peculiarities, which had not been described yet </plain></SENT>
<SENT sid="2" pm="."><plain>The cytogenetic alterations were 4q deletion and the Philadelphia (Ph) chromosome which appeared at different moments of the disease </plain></SENT>
<SENT sid="3" pm="."><plain>One patient showed the Ph chromosome at disease transformation and the other at diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>The different breakpoints at 4q and the presence of Ph could be a marker of this form of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The association of clinical and hematological findings suggests the possibility of a new group of pediatric <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>